The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

Graphical abstract

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2015-02, Vol.62 (2), p.311-316
Hauptverfasser:	Londoño, Maria-Carlota, Perelló, Christie, Cabezas, Joaquín, Cañete, Nuria, Lens, Sabela, Mariño, Zoe, Gambato, Martina, Rodríguez, Raquel, Menéndez, Susana, Carrión, José A, Crespo, Javier, Calleja, José Luis, Forns, Xavier
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Bacterial Infections - epidemiology Bacterial Infections - etiology Cirrhosis Drug Therapy, Combination Female Follow-Up Studies Gastroenterology and Hepatology Genotype Hepacivirus - genetics Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Incidence Infections Liver Cirrhosis - complications Male Middle Aged Prognosis Protease Inhibitors - adverse effects Protease Inhibitors - therapeutic use Retrospective Studies Risk Factors RNA, Viral - genetics Spain - epidemiology Triple therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!